Back    Zoom +    Zoom -
《業績》昭衍新藥(06127.HK)首季淨利潤2.38億人民幣 增長479.7%
Recommend
2
Positive
0
Negative
0
aacat by AASTOCKS
Open a new trading account to get Level 1 Real-Time Streaming!
昭衍新藥(06127.HK)公布第一季度報告，按中國會計準則，營業收入3.16億人民幣(下同)，按年增加10%。歸屬股東淨利潤2.38億元，增長479.7%，主要是生物資產公允價值變動收益增加；每股收益32分。(de/d)

AASTOCKS新聞
Switch to Auto-Translated Version
  • Remark
  • (1) HK Indices are real time
Home|RT Quote|Market|News|Indices
Feedback|Disclaimer
View: Mobile|Desktop
Lang: 繁|简|EN
Back To Top
Contact Us
Email: support@aastocks.com